Notice: Guidance Document: Post-Drug Identification Number (DIN) Changes

Notice: Guidance Document: Post-Drug Identification Number (DIN) Changes This guidance document applies to drugs regulated under Part C, Division 1 of the Regulations that have received a DIN pursuant to Section C.01.014.2. This includes pharmaceuticals for human and veterinary use, as well as disinfectant drugs, but excludes biologics and radiopharmaceuticals and any drug that has received an NOC. 2023-12-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetynoticeguidancepost-drug identification-numberDIN changesdrugs regulated under-part-C Notice: Guidance Document: Post-Drug Identification Number (DIN) ChangesHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-guidance-document-post-drug-identification-number-changes.html Notice: Guidance Document: Post-Drug Identification Number (DIN) ChangesHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/avis-ligne-directrice-changements-effectues-apres-emission-identification-numerique-drogue.html

This guidance document applies to drugs regulated under Part C, Division 1 of the Regulations that have received a DIN pursuant to Section C.01.014.2. This includes pharmaceuticals for human and veterinary use, as well as disinfectant drugs, but excludes biologics and radiopharmaceuticals and any drug that has received an NOC.

Data and Resources

Similar records